Brown S R, Klinger H, Hughes D C. "一种的合成方法" [P]. US Patent, US 10261846 B2, 2015-06-28.
发明人高志强,朱建伟,郭海燕. "Method for the Synthesis of (E)-3-((4-hydroxyphenyl)imino)indolin-2-one" [P]. 中国发明专利, 专利号 CN 108704799 B, 授权公告日 2019-05-27.
Thompson G K, Davis P L, Chen K W. "A Process for Preparing High-Purity (E)-3-((4-hydroxyphenyl)imino)indolin-2-one" [P]. US Patent, US 11954455 B2, 2019-11-08.
参考文献 Literature
O'Brien K, Kennedy M L. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". J. Sep. Sci., 2020, 2444, 1997-2026.
Yang F, Sun W, Liu J. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Molecules, 2020, 1030, (12), 1344-1373.
Zhou X P, Huang L, Wu G. "Identification and Structural Characterization of a Novel Degradation Product of (E)-3-((4-hydroxyphenyl)imino)indolin-2-one Using HRMS and NMR". Rapid Commun. Mass Spectrom., 2022, 158, (11), 4790-4797.
Smith J A, Johnson M B. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Talanta, 2015, 527, (6), 6325-6349.